|Articles|December 10, 2018
FDA Approves Celltrion and Teva’s Biosimilar to Rituxan
Author(s)BioPharm International Editors
FDA has approved Truxima (rituximab-abbs), a biosimilar to Roche’s anti-cancer biologic, Rituxan (rituximab).
Advertisement
Internal server error